HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Accepted manuscript (PDF) All Versions of this Article: JOE-09-0132v1 202/3/431    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Kim, S. Articles by Park, S. PubMed PubMed Citation Articles by Kim, S. Articles by Park, S.

S Kim, Pharmacology, Kyunghee University School of Medicine,, Seoul, Korea, Republic of
M Moon, Pharmacology, Kyunghee University School of Medicine,, Seoul, Korea, Republic of
S Park, Pharmacology, Kyunghee University School of Medicine, Seoul, 130-701, Korea, Republic of

Correspondence: Seungjoon Park, Email: sjpark{at}khu.ac.kr

Exendin-4 is a naturally occurring more potent and stable analogue of glucagon-like peptide-1 (GLP-1) that selectively binds at the GLP-1 receptor. It has been recently demonstrated that GLP-1 receptor stimulation preserves dopaminergic neurons in cellular and rodent models of Parkinson’s disease (PD). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes nigrostriatal dopaminergic neurotoxicity in rodents; previous studies suggest that activated microglia actively participate in the pathogenesis of PD neurodegeneration. However, the role of microglia in the neuroprotective properties of exendin-4 is still unknown. Here we show that, in the mouse MPTP PD model, systemic administration of exendin-4 significantly attenuates the loss of substantia nigra pars compacta (SNpc) neurons and the striatal dopaminergic fibers. Exendin-4 prevents MPTP-induced microglial activation in the SNpc and striatum, and the expression of matrix metalloproteinase-3. In addition exendin-4 also suppressed MPTP-induced expression of pro-inflammatory molecules tumor necrosis factor and interleukin-1β. Our data indicate that exendin-4 may act as a survival factor for dopaminergic neurons by functioning as a microglia-deactivating factor and suggest that exendin-4 may be a valuable therapeutic agent for neurodegenerative diseases such as PD.